Human Lung Cancer Tissue Lysates

Pricing
Normal Lysates:  $125/100 ug
Tumor Lysates:   $175/100 ug
Nor./Tum. set: $270.00 (10% off)
Discounts
2-8    Vials  10%
9-20  Vials  15%
>20   Vials  20%

Call, Fax, or Email Your Order!

Introduction:

LUNG NSCLC:

Non-small cell lung cancer can be classified based on their cellular origins and further divided into a number of subtypes according to The New World Health Organization/International Association for the Study of Lung Cancer. Histologic Classification of Non-Small Cell Lung Carcinomas. These include:

Squamous cell carcinoma - Papillary, Clear cell, Small cell, Basaloid.

Adenocarcinoma - Acinar, Papillary, Bronchioloalveolar carcinoma (Nonmucinous, Mucinous, Mixed mucinous and nonmucinous or indeterminate cell type), Solid adenocarcinoma with mucin, Adenocarcinoma with mixed subtypes, Variants (Well-differentiated fetal adenocarcinoma, Mucinous (colloid) adenocarcinoma, Mucinous cystadenocarcinoma, Signet ring adenocarcinoma, Clear cell adenocarcinoma).

Large cell carcinoma - Variants (Large-cell neuroendocrine carcinoma, Combined large-cell neuroendocrine carcinoma, Basaloid carcinoma, Lymphoepithelioma-like carcinoma, Clear cell carcinoma, Large-cell carcinoma with rhabdoid phenotype).

Adenosquamous carcinoma.
Carcinomas with pleomorphic, sarcomatoid or sarcomatous elements - Carcinomas with spindle and/or giant cells, Spindle cell carcinoma, Giant cell carcinoma, Carcinosarcoma, Pulmonary blastoma.

Carcinoid tumor - Typical carcinoid, Atypical carcinoid. Carcinomas of salivary-gland type - Mucoepidermoid carcinoma, Adenoid cystic carcinoma, Others.

Unclassified carcinoma.

LUNG SCLC:

The current classification of subtypes of small cell lung cancer is:
Small cell carcinoma. Mixed small cell/large cell carcinoma.

Combined small cell carcinoma (i.e., small cell lung cancer combined with neoplastic squamous and/or glandular components).

Human Lung Cancer Tissue Lysates

Catalog Number

Diagnosis

Grade

Stage

TNM

Sex

Age

T1-001

Papillary Adenocarcinoma

2

IIIA

T3N0M0

M

42

T1-002

Adenocarcinoma

2

II

T2N1M0

M

73

T1-003

Papillary Adenocarcinoma

2

II

T1N0M0

M

50

T1-004

Adenocarcinoma

2

n/a

n/a

M

74

T1-005

Adenocarcinoma

3

IB

T2N0M0

M

45

T1-006

Papillary Adenocarcinoma

2

I

T1N0M0

M

46

T1-007

Adenocarcinoma

2

I

T1N0M0

M

42

T1-008

Adenocarcinoma

2

I

T1N0M0

M

59

T1-009

Papillary Adenocarcinoma

2

IIIA

T3N0M0

M

63

T1-010

Papillary Adenocarcinoma

1

IIIA

T3N0M0

M

68

T1-011

Adeno-Squamous Cell Carcinoma

2

I

T1N0M0

M

72

T1-012

Adeno-Squamous Cell Carcinoma

2

I

T2N0M0

M

62

T1-013

Adeno-Squamous Cell Carcinoma

3

III

T3NxM0

M

68

T1-014

Large Cell Carcinoma

3

III

T3NxM0

M

26

T1-015

Large Cell Carcinoma

3

III

T3N0Mx

M

70

T1-016

Large Cell Carcinoma

3

III

n/a

M

55

T1-017

Large Cell Carcinoma

3

I

T2N0M0

M

68

T1-018

Large Cell Carcinoma

3

I

n/a

M

61

T1-019

Large Cell Carcinoma

2

IIIA

T3N0M0

M

31

T1-020

Large Cell Carcinoma

3

II

T2N0Mx

M

63

T1-021

Large Cell Carcinoma

3

III

n/a

M

59

T1-022

Large Cell Carcinoma

3

III

n/a

M

46

T1-023

Large Cell Carcinoma

1

I

T2N0M0

M

69

T1-024

Small Cell Carcinoma

3

IIB

T2N1M0

M

73

T1-025

Adenocarcinoma

2

n/a

n/a

F

40

T1-026

Squamous Cell Carcinoma

2

IIIA

T3N0M0

M

50

T1-027

Squamous Cell Carcinoma

2

I

T2N0M0

M

45

T1-028

Squamous Cell Carcinoma

2

I

T2N0M0

M

51

T1-029

Squamous Cell Carcinoma

2

I

T2N0M0

M

74

T1-030

Squamous Cell Carcinoma

2

III

T3N0M0

M

69

T1-031

Squamous Cell Carcinoma

2

III

T3N0M0

M

55

T1-032

Squamous Cell Carcinoma

2

III

T3N2M0

M

73

T1-033

Squamous Cell Carcinoma

3

IIIA

T3N0M0

M

60

T1-034

Squamous Cell Carcinoma

3

n/a

n/a

M

37

T1-035

Squamous Cell Carcinoma

3

III

T3N0M0

M

62

T1-036

Squamous Cell Carcinoma

2

I

T1N0M0

M

58

T1-037

Squamous Cell Carcinoma

2

II

T2N0M0

M

40

T1-038

Squamous Cell Carcinoma

2

I

T1N0M0

M

69

T1-039

Squamous Cell Carcinoma

2

I

T1N0M0

M

70

T1-040

Squamous Cell Carcinoma

2

I

T2N0M0

M

50

T1-041

Adenocarcinoma

n/a

n/a

T1N0M0

F

67

T1-042

Adenocarcinoma

n/a

I

T1N0M0

F

61

T1-043

Adenocarcinoma

n/a

IV

T2N1M1

F

80

T1-044

Adenocarcinoma

n/a

IIIA

T3N0M0

F

64

T1-045

Adenocarcinoma

2

II

T2N0Mx

F

51

T1-046

Adenocarcinoma

2

IB

T2N0Mx

F

56

T1-047

Adenocarcinoma

2

II

T2N0Mx

F

63

T1-048

Adenocarcinoma

2

II

T2N0Mx

F

66

T1-049

Adenocarcinoma

2

II

T2N0Mx

F

53

T1-050

Adenocarcinoma

3

n/a

n/a

F

70

T1-051

Adenocarcinoma

2

II

T2N0Mx

F

32

T1-052

Adenocarcinoma

2

IB

T2N0Mx

F

59

T1-053

Large Cell Carcinoma

n/a

n/a

n/a

F

45

T1-054

Large Cell Carcinoma

n/a

n/a

T2N0M0

F

54

T1-055

Large Cell Carcinoma

n/a

n/a

T3N1Mx

F

60

T1-056

Small Cell Carcinoma

n/a

II

n/a

F

56

T1-057

Spindle Cell Carcinoma

n/a

I

T2N0M0

F

25

T1-058

Papillary Carcinoma

1

IIIA

T3N0M0

F

41

 

References:

Travis WD, Colby TV, Corrin B, et al.: Histological typing of lung and pleural tumours. 3rd ed. Berlin: Springer-Verlag, 1999.

American Cancer Society.: Cancer Facts and Figures 2006. Atlanta, GA: American Cancer Society, 2006. Also available online. Last accessed May 20, 2006.